Published in
Elsevier, European Urology, 3(85), p. 274-282, 2024
DOI: 10.1016/j.eururo.2023.05.009
Links
Tools
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA
Journal article published in 2024 by
Emeline Colomba 
,
Sarah Flora Jonas,
Jean-Christophe Eymard,
Rémi Delva,
Pierre Emmanuel Brachet,
Yann Neuzillet,
Nicolas Penel,
Guilhem Roubaud,
Emmanuelle Bompas,
Hakim Mahammedi,
Raffaelle Longo,
Carole Helissey,
Philippe Barthélemy,
Delphine Borchiellini,
Ali Hasbini
and other authors.
,
Sarah Flora Jonas,
Jean-Christophe Eymard,
Rémi Delva,
Pierre Emmanuel Brachet,
Yann Neuzillet,
Nicolas Penel,
Guilhem Roubaud,
Emmanuelle Bompas,
Hakim Mahammedi,
Raffaelle Longo,
Carole Helissey,
Philippe Barthélemy,
Delphine Borchiellini,
Ali Hasbini
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 